Current Affairs · Science and Technology
Which cutting-edge cancer treatment, jointly developed by IIT Bombay and Tata Memorial Centre, received DCGI approval for Phase-1 trials in December 2024?
Verified Solution4 OptionsUpdated: October 2026👁️1 View
Share:
- 1Oncolytic viral therapy
- 2CRISPR-Cas9 gene editing
- 3CAR-T cell therapy✓
- 4siRNA nanotherapy
Correct answer
CAR-T cell therapy
Download Single Question PDF
Save this question and verified answer as a clean study sheet with live clickable link.
👥
Share with Friends & Study Groups
Challenge your peer aspirants on WhatsApp or Telegram to solve this question!
Online Test Series
Start Free Mock Test →Preparing for Current Affairs?
Practice full-length mock tests with real exam timers, instant score analysis, and all-India ranking.
Chapter Practice
Practice Science and Technology MCQs →Want more practice questions on Science and Technology?
Solve complete topic-wise tests with detailed solutions on GkGet.
Related Practice Questions
Recommended practice questions in Current Affairs · Science and Technology